0000878088-11-000078.txt : 20111219
0000878088-11-000078.hdr.sgml : 20111219
20111219144200
ACCESSION NUMBER: 0000878088-11-000078
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111215
FILED AS OF DATE: 20111219
DATE AS OF CHANGE: 20111219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NORDMANN RONALD M
CENTRAL INDEX KEY: 0001189790
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10827
FILM NUMBER: 111268986
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC.
CENTRAL INDEX KEY: 0000878088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223122182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TICE BOULEVARD
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
BUSINESS PHONE: 201-802-4000
MAIL ADDRESS:
STREET 1: 300 TICE BOULEVARD
CITY: WOODCLIFF LAKE
STATE: NJ
ZIP: 07677
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC
DATE OF NAME CHANGE: 19940526
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2011-12-15
0
0000878088
PAR PHARMACEUTICAL COMPANIES, INC.
PRX
0001189790
NORDMANN RONALD M
C/O PAR PHARMACEUTICAL COMPANIES INC.
300 TICE BLVD.
WOODCLIFF LAKE
NJ
07677
1
0
0
0
Common Stock
2011-12-15
4
M
0
2500
29.9
A
6500
D
Common Stock
2011-12-15
4
S
0
200
32.5007
D
6300
D
Common Stock
2011-12-15
4
S
0
2200
32.5
D
4100
D
Common Stock
2011-12-15
4
S
0
100
32.502
D
4000
D
Common Stock, Option to buy
29.9
2011-12-15
4
M
0
2500
0
D
2003-01-08
2012-01-07
Common Stock
2500
0
D
Mr. Nordmann was granted an option to purchase 2,500 shares of Common Stock under the Company's 1997 Directors Stock and Deferred Fee Plan on January 8, 2002, all of which vested on January 8, 2003. The expiration date of this option is January 7, 2012.
LIMITED POWER OF ATTORNEY: KNOW ALL MEN BY THESE PRESENTS, that the undersigned does hereby constitute and appoint MARIAN E. GUSTAFSON with full power to act, as his/her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him/her and in his/her name, place and stead, in any and all capacities, and to do any and all acts and things in his/her name and on his/her behalf, to execute any and all documents and instruments, which said attorney-in-fact may deem necessary or advisable to enable him/her to comply with the reporting requirements pursuant to Section 16 of the Securities Exchange Act of 1934, as amended, including but not limited to Form 4-Statement of Changes in Beneficial Ownership and Form 5-Annual Statement of Changes in Beneficial Ownership, relating to his/her ownership in Par Pharmaceutical Companies, Inc. (the "Company") for the period October 1, 2011 through and including September 30, 2012; and to file the same, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that the said attorney-in-fact and agent may lawfully do or cause to be done by virtue thereof. /s/ Ronald M. Nordmann Dated: September 9, 2011
/s/ Marian E. Gustafson for Ronald M. Nordmann
2011-12-19